Our cohort was analyzed for two key molecular features of colorectal cancer, mismatch repair deficiency, and BRAF status, which enabled us to study the prognostic significance of immune cells independent of these factors. The gene discussed is BRAF; the disease is mismatch repair cancer syndrome 1.